Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
3.06M
-
Shares change
-
+1.81M
-
Total reported value, excl. options
-
$3.24M
-
Value change
-
+$2.16M
-
Number of buys
-
19
-
Number of sells
-
-5
-
Price
-
$1.06
Significant Holders of iBio, Inc. - Common Stock (IBIO) as of Q1 2020
27 filings reported holding IBIO - iBio, Inc. - Common Stock as of Q1 2020.
iBio, Inc. - Common Stock (IBIO) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.06M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (949K shares), BlackRock Inc. (823K shares), GEODE CAPITAL MANAGEMENT, LLC (325K shares), Thrivent Financial for Lutherans (318K shares), JANE STREET GROUP, LLC (100K shares), GOLDMAN SACHS GROUP INC (97K shares), MILLENNIUM MANAGEMENT LLC (87.1K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (86.7K shares), NORTHERN TRUST CORP (64.8K shares), and Bank of New York Mellon Corp (46.6K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.